{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T04:00:16Z","timestamp":1648699216077},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.mehy.2012.01.039","type":"journal-article","created":{"date-parts":[[2012,2,15]],"date-time":"2012-02-15T13:18:37Z","timestamp":1329311917000},"page":"619-620","source":"Crossref","is-referenced-by-count":0,"title":["Can snus (Swedish moist snuff) be used as a treatment of Pyoderma gangrenosum?"],"prefix":"10.1016","volume":"78","author":[{"given":"Nicolas","family":"Kluger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mehy.2012.01.039_b0005","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jaad.2006.07.016","article-title":"From acute febrile neutrophilic dermatosis to neutrophilic disease: 40years of clinical research","volume":"55","author":"Wallach","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.mehy.2012.01.039_b0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1529-8019.2011.01403.x","article-title":"Diagnosis and treatment of the neutrophilic dermatoses (pyoderma gangrenosum, sweet\u2019s syndrome)","volume":"24","author":"Dabade","year":"2011","journal-title":"Dermatol Ther"},{"issue":"2","key":"10.1016\/j.mehy.2012.01.039_b0015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaad.2004.10.006","article-title":"Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients","volume":"53","author":"Reichrath","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.mehy.2012.01.039_b0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archdermatol.2010.393","article-title":"Is topical monotherapy effective for localized pyoderma gangrenosum?","volume":"147","author":"Le Cleach","year":"2011","journal-title":"Arch Dermatol"},{"issue":"8956","key":"10.1016\/j.mehy.2012.01.039_b0025","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0140-6736(95)90802-1","article-title":"Nicotine for pyoderma gangrenosum","volume":"345","author":"Kanekura","year":"1995","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.mehy.2012.01.039_b0030","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1346-8138.1995.tb03904.x","article-title":"Successful treatment of pyoderma gangrenosum with nicotine chewing gum","volume":"22","author":"Kanekura","year":"1995","journal-title":"J Dermatol"},{"issue":"9","key":"10.1016\/j.mehy.2012.01.039_b0035","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/archderm.134.9.1071","article-title":"Nicotine for pyoderma gangrenosum","volume":"134","author":"Wolf","year":"1998","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.mehy.2012.01.039_b0040","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/09546630310019364","article-title":"Successful treatment of pyoderma gangrenosum with topical 0.5% nicotine cream","volume":"15","author":"Patel","year":"2004","journal-title":"J Dermatolog Treat"},{"issue":"8\u20139","key":"10.1016\/j.mehy.2012.01.039_b0045","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0192-0561(96)00054-9","article-title":"The effect of nicotine on murine CD4 T cell responses","volume":"18","author":"Zhang","year":"1996","journal-title":"Int J Immunopharmacol"},{"issue":"11","key":"10.1016\/j.mehy.2012.01.039_b0050","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1111\/j.1572-0241.2008.02094_11.x","article-title":"Toll-like receptor-4 signaling: a possible candidate pathway to support tobacco smoking effects in ulcerative colitis","volume":"103","author":"Savoye","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.mehy.2012.01.039_b0055","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/ibd.20523","article-title":"Does nicotine influence cytokine profile and subsequent cell cycling apoptotic responses in inflammatory bowel disease","volume":"14","author":"Aldhous","year":"2008","journal-title":"Inflamm Bowel Dis"},{"issue":"14","key":"10.1016\/j.mehy.2012.01.039_b0060","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.clinthera.2011.01.004","article-title":"Systematic review and meta-analysis of the efficacy and tolerability of nicotine preparations in active ulcerative colitis","volume":"32","author":"Nikfar","year":"2010","journal-title":"Clin Ther"},{"issue":"2","key":"10.1016\/j.mehy.2012.01.039_b0065","first-page":"87","article-title":"Relationship between CYP2A6 genetic polymorphism, as a marker of nicotine metabolism, and ulcerative colitis","volume":"13","author":"Altarescu","year":"2011","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.mehy.2012.01.039_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/rtph.1998.1229","article-title":"A qualitative and quantitative risk assessment of snuff dipping","volume":"28","author":"Nilsson","year":"1998","journal-title":"Regul Toxicol Pharmacol"},{"issue":"2","key":"10.1016\/j.mehy.2012.01.039_b0075","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.yrtph.2010.12.002","article-title":"Summary of the epidemiological evidence relating snus to health","volume":"59","author":"Lee","year":"2011","journal-title":"Regul Toxicol Pharmacol"},{"issue":"9","key":"10.1016\/j.mehy.2012.01.039_b0080","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1046\/j.1360-0443.2003.00379.x","article-title":"Swedish cancer society; pharmacia AB. Role of snus (oral moist snuff) in smoking cessation and smoking reduction in Sweden","volume":"98","author":"Gilljam","year":"2003","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.mehy.2012.01.039_b0085","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1046\/j.1360-0443.2003.00442.x","article-title":"Should the European Union lift the ban on snus? Evidence from the Swedish experience","volume":"98","author":"Fagerstr\u00f6m","year":"2003","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.mehy.2012.01.039_b0090","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1046\/j.1360-0443.2003.00477.x","article-title":"Snus part of the problem or part of the solution","volume":"98","author":"Ramstrom","year":"2003","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.mehy.2012.01.039_b0095","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1046\/j.1360-0443.2003.00479.x","article-title":"Swedish snuff: a hazardous experiment when interpreting scientific data into public health ethics","volume":"98","author":"Bolinder","year":"2003","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.mehy.2012.01.039_b0100","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2105\/AJPH.82.3.417","article-title":"Smokeless tobacco, cardiovascular risk factors, and nicotine and cotinine levels in professional baseball players","volume":"82","author":"Siegel","year":"1992","journal-title":"Am J Public Health"},{"issue":"3","key":"10.1016\/j.mehy.2012.01.039_b0105","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/14622200500125468","article-title":"Steady-state nicotine plasma levels following use of four different types of Swedish snus compared with 2-mg Nicorette chewing gum: a crossover study","volume":"7","author":"Lunell","year":"2005","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"10.1016\/j.mehy.2012.01.039_b0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.lpm.2011.06.005","article-title":"Snus","volume":"41","author":"Underner","year":"2012","journal-title":"Presse Med"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987712000606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987712000606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T05:20:06Z","timestamp":1543209606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987712000606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0306987712000606"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2012.01.039","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}